Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared a post on LinkedIn:
“It is time for some ‘creative destruction’ in cancer care. Sustained growth requires the courage to let new innovations replace obsolete ones.
Heading home tonight after another impactful ACCC meeting. Two days in the company of some of the smartest, most innovative leaders in all of oncology.
I particularly enjoyed the honest, unfiltered conversations – including the practical wisdom shared by my panel guests for our our panel: AI in Oncology: Tools for Today, Breaking and Remaking for Tomorrow.
Thank you to my brilliant colleagues, Lucio N. Gordan, Debra Patt, Ashley Gigandet Joseph, and Sanjay Juneja.
ACCC gets the right people in the same room and creates enough trust for the conversation to be real. Senior decision-makers carrying actual operational weight. You hear the version with scar tissue, not the one edited for a press release.
The programs pulling ahead have made one reframe. They stopped asking whether the AI is ready and started asking whether their organizations are. Those are completely different questions. The gap between programs that have made that shift and those that haven’t is widening every quarter.
Takehome point: We cannot simply let this AI engine run. We must steer it.”
Other Articles Featuring Douglas Flora on OncoDaily.
